Related Experiment Video
Updated: May 25, 2025

An Effective Mouse Model of Unilateral Renal Ischemia-Reperfusion Injury
Published on: July 15, 2021
Oxidative stress and NRF2 signaling in kidney injury
Cherry Ng1, Maxine Kim1, Yanti2
1Department of Pharmacy and BK21FOUR Advanced Program for Smart Pharma Leaders, Graduate School of The Catholic University of Korea, Gyeonggi-do, 14662 Republic of Korea.
Abstract:
Oxidative stress plays a crucial role in the pathogenesis of acute kidney injury (AKI), chronic kidney disease (CKD), and the AKI-to-CKD transition. This review examines the intricate relationship between oxidative stress and kidney pathophysiology, emphasizing the potential therapeutic role of nuclear factor erythroid 2-related factor 2 (NRF2), a master regulator of cellular redox homeostasis. In diverse AKI and CKD models, diminished NRF2 activity exacerbates oxidative stress, whereas genetic and pharmacological NRF2 activation alleviates kidney damage induced by nephrotoxic agents, ischemia-reperfusion injury, fibrotic stimuli, and diabetic nephropathy. The renoprotective effects of NRF2 extend beyond antioxidant defense, encompassing its anti-inflammatory and anti-fibrotic properties. The significance of NRF2 in renal fibrosis is further underscored by its interaction with the transforming growth factor-β signaling cascade. Clinical trials using bardoxolone methyl, a potent NRF2 activator, have yielded both encouraging and challenging outcomes, illustrating the intricacy of modulating NRF2 in human subjects. In summary, this overview suggests the therapeutic potential of targeting NRF2 in kidney disorders and highlights the necessity for continued research to refine treatment approaches.
Insights
Targeting the NRF2 pathway shows promise for treating kidney diseases like acute kidney injury (AKI) and chronic kidney disease (CKD). Activating NRF2 (nuclear factor erythroid 2-related factor 2) can protect kidneys from damage and reduce fibrosis.
Area of Science:
- Nephrology
- Molecular Biology
- Pathophysiology
Background:
- Oxidative stress is a key factor in the development and progression of kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD).
- The nuclear factor erythroid 2-related factor 2 (NRF2) is a critical regulator of cellular antioxidant responses and redox homeostasis.
- Dysregulation of NRF2 contributes to kidney damage in various pathological conditions.
Purpose of the Study:
- To review the complex interplay between oxidative stress and kidney pathophysiology.
- To explore the therapeutic potential of NRF2 activation in mitigating kidney damage and fibrosis.
- To discuss the clinical implications and challenges of targeting NRF2 for kidney disorders.
Main Methods:
- Review of existing literature on oxidative stress, NRF2, and kidney disease.
- Analysis of data from preclinical models of AKI and CKD.
- Examination of findings from clinical trials involving NRF2 activators.
Main Results:
- Reduced NRF2 activity worsens kidney damage in AKI and CKD models.
- NRF2 activation demonstrates renoprotective effects against various insults, including toxins, ischemia-reperfusion, and diabetic nephropathy.
- NRF2 exerts anti-inflammatory and anti-fibrotic effects, partly through interaction with TGF-β signaling.
Conclusions:
- NRF2 activation holds significant therapeutic potential for managing kidney diseases.
- Modulating NRF2 activity in humans presents complexities, as evidenced by clinical trial outcomes.
- Further research is essential to optimize NRF2-targeted therapies for renal disorders.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Peroxisomes

